Rocket Pharmaceuticals In... (RCKT)
NASDAQ: RCKT
· Real-Time Price · USD
3.04
0.01 (0.33%)
At close: Aug 15, 2025, 3:59 PM
3.05
0.16%
After-hours: Aug 15, 2025, 04:10 PM EDT
0.33% (1D)
| Bid | 3 |
| Market Cap | 328.57M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -258.03M |
| EPS (ttm) | -2.51 |
| PE Ratio (ttm) | -1.21 |
| Forward PE | -1.87 |
| Analyst | Buy |
| Ask | 3.2 |
| Volume | 1,221,255 |
| Avg. Volume (20D) | 4,829,738 |
| Open | 3.04 |
| Previous Close | 3.03 |
| Day's Range | 3.04 - 3.15 |
| 52-Week Range | 2.19 - 22.01 |
| Beta | 0.65 |
About RCKT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RCKT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RCKT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Rocket Pharmaceuticals Inc. is scheduled to release its earnings on
Nov 6, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
+4.32%
Shares of several biotechnology stocks are trading...
Unlock content with
Pro Subscription
4 weeks ago
+16.78%
Rocket Pharmaceuticals shares are trading higher after the company received FDA Regenerative Medicine Advanced Therapy designation for RP-A601 gene therapy in PKP2-arrhythmogenic cardiomyopathy.
